Next Article in Journal
A Preliminary Study on Cross-Reactivity of Heat-Treated Quail and Hen’s Egg White Proteins in Young Children
Next Article in Special Issue
Impact of Hyponatremia after Renal Transplantation on Decline of Renal Function, Graft Loss and Patient Survival: A Prospective Cohort Study
Previous Article in Journal
Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
Previous Article in Special Issue
Geospatial Analysis of Sodium and Potassium Intake: A Swiss Population-Based Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 13
Issue 7
10.3390/nu13072174
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Aerobic Exercise Training Prevents Insulin Resistance and Hepatic Lipid Accumulation in LDL Receptor Knockout Mice Chronically Fed a Low-Sodium Diet

by
Guilherme da Silva Ferreira
1,
Ana Paula Garcia Bochi
1,
Paula Ramos Pinto
1,
Vanessa Del Bianco
1,
Letícia Gomes Rodrigues
1,
Mychel Raony Paiva Teixeira Morais
2,
Edna Regina Nakandakare
1,
Ubiratan Fabres Machado
3,
Sergio Catanozi
1,† and
Marisa Passarelli
1,4,*,†
1
Laboratorio de Lipides (LIM-10), Hospital das Clinicas (HCFMUSP) da Faculdade de Medicina da Universidade de São Paulo, São Paulo 01246-903, Brazil
2
Department of Cell and Development Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil
3
Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil
4
Programa de Pós-Graduação em Medicina, Universidade Nove de Julho, São Paulo 01525-000, Brazil
*
Author to whom correspondence should be addressed.
†
Both senior authors contributed equally to this work.
Nutrients 2021, 13(7), 2174; https://doi.org/10.3390/nu13072174
Submission received: 26 April 2021 / Revised: 11 June 2021 / Accepted: 17 June 2021 / Published: 24 June 2021
(This article belongs to the Special Issue Dietary Sodium and Human Health)
Browse Figures
Versions Notes

Abstract

:
Background: A low-sodium (LS) diet reduces blood pressure, contributing to the prevention of cardiovascular diseases. However, intense dietary sodium restriction impairs insulin sensitivity and worsens lipid profile. Considering the benefits of aerobic exercise training (AET), the effect of LS diet and AET in hepatic lipid content and gene expression was investigated in LDL receptor knockout (LDLr-KO) mice. Methods: Twelve-week-old male LDLr-KO mice fed a normal sodium (NS) or LS diet were kept sedentary (S) or trained (T) for 90 days. Body mass, plasma lipids, insulin tolerance testing, hepatic triglyceride (TG) content, gene expression, and citrate synthase (CS) activity were determined. Results were compared by 2-way ANOVA and Tukey’s post-test. Results: Compared to NS, LS increased body mass and plasma TG, and impaired insulin sensitivity, which was prevented by AET. The LS-S group, but not the LS-T group, presented greater hepatic TG than the NS-S group. The LS diet increased the expression of genes related to insulin resistance (ApocIII, G6pc, Pck1) and reduced those involved in oxidative capacity (Prkaa1, Prkaa2, Ppara, Lipe) and lipoprotein assembly (Mttp). Conclusion: AET prevented the LS-diet-induced TG accumulation in the liver by improving insulin sensitivity and the expression of insulin-regulated genes and oxidative capacity.

1. Introduction

Dietary sodium restriction reduces blood pressure (BP) contributing to preventing cardiovascular diseases (CVD). Less than 2 g of sodium/day (corresponding to 5 g of sodium chloride) is recommended by the World Health Organization as a public health strategy to deal with cardiovascular morbidity and mortality [1]. However, recent observational studies have indicated a U- or J-shaped curve for CVD or mortality related to daily sodium consumption below 3 g or above 7 g [2]. Long-term intensive sodium restriction in the diet activates the renin-angiotensin-aldosterone system (RAAS), and the sympathetic nervous system favoring insulin resistance. Those events contribute to the increase in plasma lipids, especially triglycerides (TG) and free fatty acids (FFA), enhanced lipid infiltration in the arterial wall, and glycoxidative stress [3]. It was recently demonstrated that LDL receptor knockout (LDLr-KO) mice chronically fed a low-sodium (LS) diet present many alterations in skeletal muscle lipidomics, namely glycerophospholipid and fatty acid species that relate to the reduced insulin sensitivity observed in those animals [4].
There are limited data on the influence of an LS diet in lipid metabolism in the liver, a central organ for lipid and glucose homeostasis. Prada et al. (2005) observed a reduced insulin sensitivity in Wistar rats fed an LS diet that was attributed to the activation of c-Jun N terminal kinase (JNK) proteins and serine phosphorylation of the insulin receptor substrate 1 (IRS-1 ser307) [5]. Xavier et al. (2003) reported greater de novo lipogenesis, although without an increase in TG content in the liver [6]. It was recently demonstrated that LS intake increased hepatic diacylglycerol, esterified cholesterol, and inflammation in mice fed with a high-fat diet for 12 weeks. However, high sodium diet-fed animals were protected against steatosis induced by a high-fat or a choline/methionine deficient diet, which was ascribed to the reduced activation of the mineralocorticoid receptor helping to reduce lipogenesis markers in the liver [7].
Regular exercise improves insulin sensitivity and lipid metabolism, reducing plasma TG and small-dense low-density lipoprotein (LDL). Moreover, it increases cholesterol in high-density lipoprotein (HDL) and ameliorates the reverse cholesterol transport and antioxidant defenses in the arterial wall [8,9]. Aerobic exercise training (AET) favors fatty acid oxidation, limits hepatic TG accumulation, and impairs the detrimental actions of fatty acid derivatives in the insulin receptor signaling cascade [10,11].
The present study investigated the effect of an intensive and chronically administered LS diet and AET in the modulation of lipid content and expression of genes related to lipid metabolism and insulin sensitivity in the liver of LDLr-KO mice.

2. Materials and Methods

2.1. Animals

C57BL/6J background homozygous LDLr-KO mice (Jackson Laboratory, Bar Harbor, ME, USA) were housed in a conventional animal facility at 22 °C ± 2, under a 12 h light/dark cycle with free access to commercial chow (Nuvilab CR1-Nuvital Nutrients, Colombo, PR, Brazil) and drinking water.

2.2. Experimental Protocol

The experimental protocol was approved by the Animal Care and Research Advisory Committee of the Faculdade de Medicina da Universidade de Sao Paulo (CEUA # 1210/2019) and it was conducted according to the U.S. National Institutes of Health Guide for the Care and Use of Laboratory Animals. Twelve-week-old mice were randomly divided into four groups in a factorial design 2 × 2 according to sodium consumption and AET: 1—normal sodium (NS) diet plus sedentary (NS-S; n = 14); 2—NS diet plus trained (NS-T; n = 13); 3—LS diet plus sedentary (LS-S; n = 13); and 4—LS diet plus trained (LS-T; n = 13). The intervention protocol lasted 90 days.
Maximum exercise capacity, body mass, systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate, hematocrit, plasma total cholesterol (TC), TG, and glucose were determined before and after the intervention. In addition, 24 h urinary sodium excretion, insulin tolerance testing (kITT), and plasma lipoprotein profile were determined only at the end of the intervention.
Mice were euthanized with an overdose of sodium thiopental (Thiopentax®; 150 mg/kg body mass) and the liver was excised. A fragment was snap-frozen in liquid nitrogen and stored at −80 °C for further analysis of lipid content, and other fragments were stored for 24 h at −20 °C and then at −80 °C in RNAlaterTM Stabilization Solution (Thermofisher Scientific, Waltham, MA, USA) for measuring gene expression or immediately processed for histological analysis.

2.3. Diet and Aerobic Exercise Training

Low-sodium (0.06% Na+; Envigo Teklad Diets; Indianapolis, IN, USA, TD 92141) and NS diets (0.5% Na; Envigo Tekald, TD92140) were similar in energy and nutrients (g/100 g): casein (28.7), sucrose (31.3), cornstarch (20.0), soybean oil (6.0), cellulose (9.79), vitamin mix (Teklad—1.0), and ethoxyquin. In the LS diet, sodium chloride was replaced for cellulose but its amount was sufficient for normal mouse growth rate. Food consumption (g/day/number of animals in cage) was measured weekly by difference from given and uneaten diet mass. For this analysis, each group of animals was considered one experimental unity.
The AET was performed on a treadmill 5 days/week, at 15 m/min, for 60 min. In the first week, mice were acclimated at a speed of 12 m/min with a gradual increase in time per session (10 min) from 30 to 60 min. Throughout the protocol, 10% of the trained animals were excluded by the incapacity of running.

2.4. Treadmill Exercise Test

A progressive treadmill exercise test until exhaustion was performed after 3 sessions of exercise (15 m/min, 10 min) as previously described [12]. The speed started at 9 m/min and 0% grade with 3 m/min at every 3 min being added until the complete inability to run, even after constantly stimulus. The time to exhaustion, the maximum time that the animal was able to run, was used as the parameter of physical conditioning.

2.5. Blood Glucose, Hematocrit, Plasma Lipids, Blood Pressure, and Urinary Sodium Excretion

Blood from the tail vein was collected (~200 µL) in heparinized capillary tubes after a 12 h overnight fasting period. Hematocrit was quantified by the microhematocrit technique. Plasma TG and TC were determined by enzymatic colorimetric kits (Labtest, Lagoa Santa, MG, Brazil) and glycemia by an Accu-Chek® Performa glucometer. SBP and DBP were assessed in conscious animals by non-invasive photoplethysmography with a computerized tail-cuff system (Visitech Systems, model BP-2000 Blood Pressure Analysis SystemTM—Apex, NC, USA). Animals were preconditioned to the method before final analyses and mean values were obtained after 8 consecutive measurements. Twenty-four hour urinary collection was accomplished in individual metabolic cages and utilized for the determination of urinary sodium in an FC 280 flame spectrophotometer (CELM; São Paulo, SP, Brazil).

2.6. Lipoprotein Profile

Plasma lipoprotein profile was determined by fast protein liquid chromatography (FPLC) on an HR 10/30 Superose 6 column with a constant flow of 0.5 mL/min of Tris-buffered saline, pH 7.2, utilizing 100 μL of plasma. The amount of TC and TG associated with very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) was determined by enzymatic techniques.

2.7. Insulin Tolerance Test

The insulin tolerance test (kITT) was performed in the 10th week after 4 h fasting. Glycemia was assessed (Accu-Chek® Performa) at basal, 10, 20, and 30 min after intraperitoneal injection of regular insulin (1 U/kg—Humulin, Eli Lilly). The glucose decay rate was determined by linear regression.

2.8. Hepatic Lipid Content

Lipid extraction was performed according to Carr et al. (1993) [13]. Briefly, 100 mg of liver tissue was macerated in a solution of chloroform:methanol (2:1, v:v) and samples were maintained overnight at –20 °C. The organic phase was separated adding aqueous solution containing 0.05% H2SO4 following centrifugation (1690× g). The solvent was dried (Genivac Standard [EZ-2], Ipswich, Suffolk, England), added with 1 mL Triton X-100 solution (0.5% in chloroform) and dried again (Genivac Standard [EZ-2], Ipswich, Suffolk, England). The sample was resuspended in 500 µL of water and heated at 37 °C for 15 min with agitation. TG and TC were determined by enzymatic colorimetric kits (Labtest, Lagoa Santa, MG, Brazil) in automated equipment (COBAS-MIRA—Roche Diagnostics, Indianapolis, IN, USA). The aqueous fraction was dried and diluted in 1 mL of 1N NaOH. Protein concentration was determined by the method of Lowry et al. (1951) [14]. TC and TG concentration was corrected by g of liver and g of protein.

2.9. Glycogen Quantification

Liver sections from the median lobe (~3.0 µm) included in paraffin were stained with Periodic Acid-Schiff (PAS). Histological sections were photographed around centrilobular veins, with a 20x objective, using an Olympus DP72 optical microscope equipped with a digital camera. For each animal, 10 microscopic fields of at least 2 cuts were quantified, using the Image J program (National Institutes of Health, USA). Results are presented as percentage of stained area.

2.10. Real-Time Quantitative PCR (RT-qPCR)

A fragment of the middle lobe (~30 mg) was macerated using 600 µL of lysis buffer (RLT, Qiagen, Hilden, North Rhine-Westphalia, Germany) with 1% beta-mercaptoethanol. RNA extraction and purification were performed using the RNeasy Mini Kit (Qiagen, Hilden, North Rhine-Westphalia, Germany). The RNA quantity and quality were performed by the Lab-on-a-Chip Approach of Agilent using a 2100 Bioanalyzer. cDNA was obtained from 1000 ng of total RNA using a commercial High-Capacity RNA-to-cDNA kit (Applied Biosystems, Thermofisher Scientific, Waltham, MA, USA). The volume of cDNA was then diluted 10x in endonuclease-free water and stored at −20 °C. mRNA expression was measured by real-time quantitative polymerase chain reaction (RT-qPCR) using TaqMan probes (Applied Biosystems, Thermofisher Scientific, Waltham, MA, USA) in Step One Plus Real-Time qPCR System (Applied Biosystems, Thermofisher Scientific, Waltham, MA, USA): Acaca, acetyl-Coenzyme A carboxylase alpha (Mm01304257_m1); Ager, advanced glycosylation end product-specific receptor (Mm00545815_m1); Apoc2, Apolipoprotein C-II (Mm00437571_m1); Apoc3, apolipoprotein C-III (Mm00445670_m1); Ddost, dolichyl-di-phosphooligosaccharide-protein glycotransferase (Mm00492100_m1); Fasn, fatty acid synthase (Mm00662319_m1); Foxa2, forkhead box A2 (Mm00839704_mH); Foxo1, forkhead box O1 (Mm00490671_m1); G6pc, glucose-6-phosphatase, catalytic (Mm00839363_m1); Il6, Interleukin-6 (Mm00446190_m1); Il10, Interleukin-10 (Mm01288386_m1); Lipe, lipase, hormone sensitive (Mm00495359_m1); Lrp1, low density lipoprotein receptor-related protein 1(Mm00464608_m1); Mttp, microsomal triglyceride transfer protein (Mm00435015_m1); Pck1, phosphoenolpyruvate carboxykinase 1, cytosolic (Mm01247058_m1); Plin1, perilipin 1(Mm00558672_m1); Ppara, peroxisome proliferator activated receptor alpha (Mm00440939_m1); Ppargc1a, peroxisome proliferative activated receptor, gamma, coactivator 1 alpha (Mm01208835_m1); Prkaa1 and Prkaa2, protein kinase, AMP-activated, alpha 1(Mm01296700_m1) and alpha 2 (Mm01264789_m1) catalytic subunit; Rela, v-rel reticuloendotheliosis viral oncogene homolog (Mm00501346_m1); Slc2a2, solute carrier family 2 (facilitated glucose transporter) member 2 (Mm00446229_m1); Srebf1 and Srebf2, sterol regulatory element binding transcription factor 1 (Mm00550338_m1) and 2 (Mm01306292_m1). The relative quantification of gene expression was calculated by using the comparative cycle threshold (CT; 2−ΔΔCT) method [15]. Beta-actin (Mm02619580_g1) was chosen as the housekeeping gene after excluding other candidate genes (Actb, Gapdh [Mm99999915_g1], Hprt [Mm03024075_m1], Rplp0 [Mm00725448_s1], Ppib [Mm00478295_m1]) after running a gene stability test (Normfinder, https://moma.dk/normfinder-software; accessed on 30 July 2019).

2.11. Citrate Synthase Activity

The activity of the citrate synthase was evaluated in liver homogenates (32 µg of protein), by measuring the rate of 5-thio-2-nitrobenzoic acid (TNB) formation at 412 nm (#CS0720, Sigma-Aldrich, St. Louis, MO, USA). The kinetic assay was performed in a 96-well plate, with a final volume of 105 µL of the reaction mixture (30 mM acetyl-Coa, 5’5-Dithio-bis-(2-nitrobenzoic) acid), 10 mM, 10 mM oxaloacetate, 32 µg of liver supernatant protein) for 2 min.

2.12. Statistical Analysis

Statistical analysis was performed using the Minitab 19 software. Data normality was checked by the Kolmogorov–Smirnov test, non-normal variables were log- or Johnson-transformed before analysis of variance. Differences at the baseline were compared by one-way ANOVA; results after intervention were compared by 2-way ANOVA (generalized linear model) with fixed factors: diet and exercise. Tukey’s post-test was applied when appropriate. In order to verify pre- and post-effects, the analyses of exercise capacity and food consumption were running by repeated measures ANOVA (mixed model; random factor: animal and fixed factors: diet, exercise, and time). Correlations between variables were determined using Spearman’s correlation test. p < 0.05 was considered statistically significant. The statistical differences could be indicated by the effect of diet (NS vs. LS), exercise (S vs. T), or interaction. When interaction was reached, distinct letters represent statistical differences among all groups (p < 0.05). Data are presented as mean ± standard deviation (SD).

3. Results

3.1. Efficiency of Interventions

As expected, a diminished 24 h urinary sodium excretion was observed in the LS as compared to the NS group (Figure 1). In AET groups, a 60% improvement in the exercise capacity was observed over time and a 79% increment in aerobic capacity was observed in comparison to sedentary animals at the end of the training protocol (Figure 2). Food intake was similar among groups (data not shown).

3.2. Metabolic Parameters

Body mass, TC, TG, blood glucose, hematocrit, SBP, and DBP were similar among groups at the beginning (Table 1). After intervention, the LS groups showed greater body mass, glycemia, and triglyceridemia compared to NS groups (Table 2). Biochemical data from NS-S and LS-S animals were presented elsewhere as a part of the evaluation of muscle lipidomics in those animals [4]. Unexpectedly, AET mice presented higher blood glucose compared to sedentary ones. Hematocrit, TC, SBP, and DBP were not altered by either diet or AET (Table 2).

3.3. Insulin Tolerance Test (kITT)

In the kITT, a reduced glucose decay rate was observed in the LS-S group as compared to others, as previously reported [4]; however, the impairment in the insulin sensitivity was prevented by AET (Figure 3).

3.4. Plasma Lipoprotein Profile

The LS diet altered lipoprotein profile, shifting cholesterol to LDL and TG to VLDL particles, while both lipids were decreased in the HDL fraction (Figure 4).

3.5. Triglyceride and Glycogen Content in the Liver

The hepatic TG content was increased in the LS-S group, but not in the LS-T group (Figure 5a,c). The content of TG was positively correlated with body mass and plasma TG, and negatively with exercise capacity, insulin sensitivity, and urinary sodium excretion (Figure 6a–e). No difference was observed in hepatic glycogen and cholesterol concentration among groups (Figure 5b,d,e). The liver mass was reduced in LS groups (Figure 5f).

3.6. Gene Expression

The expressions of Apoc3 (that encodes for apoCIII, an inhibitor of lipoprotein lipase, LPL), and Lrp1 (p = 0.06; that encodes for LRP-1, the receptor of lipoproteins that contain ApoE) were enhanced by the LS diet (Figure 7a). However, the expression of Ppara and Prkaa1 (p = 0.06) and 2 (that encodes for PPARα, AMPKα1 e α2 key proteins in oxidative metabolism), Lipe (that encodes for hormone sensitive lipase, responsible for the hydrolysis of TG), Mttp (that encodes for MTP, important for the VLDL assembly), and Srebf2, (that encodes for SREBP2, a transcription factor that regulates cholesterol homeostasis) were diminished by the LS diet. The AET only increased the expression of Lipe in the NS-T group as compared to the other groups (Figure 7a). Moreover, the LS diet increased the expression of genes related to glucose metabolism, G6pc and Pck1, both enzymes of gluconeogenesis, and the anti-inflammatory and antioxidative gene, Ddost (that encodes AGR1, a receptor that counteracts the oxidative and inflammatory response elicited by glycoxidative stress) (Figure 7a). Other genes involved in lipid metabolism (Acaca, Fasn, ApoC2, Plin1, Ppargc1a, Srebf1), insulin signaling (Foxa2, Foxo1, Scl2a2), and inflammation (Ager, Il6, Il10, Rela) were not altered by diet and AET (Figure 7b).

3.7. Citrate Synthase Activity

The activity of citrate synthase was higher in the LS-T group as compared to other groups (Figure 8a) and it was positively correlated to exercise capacity (Figure 8b).

4. Discussion

In this investigation, it was demonstrated that AET prevented insulin resistance and fat accumulation in the liver of dyslipidemic mice chronically fed a LS diet. Dietary sodium restriction plays a beneficial role in reducing BP and associated comorbidities, although a negative interference in lipid and glucose homeostasis has been described in humans and animal models [3,16,17,18]. In the LDLr-KO dyslipidemic mice, the effects of an intensive dietary sodium restriction in enhancing plasma TG and worsening insulin resistance as firstly demonstrated in rats were confirmed [19]. In those animals, plasma TG enhanced 71% as compared to rats in the NS diet that was attributed to a reduction in VLDL catabolism by the LPL independently of changes in hepatic TG synthesis [19].
Insulin modulates the metabolism of TG-rich lipoproteins (namely chylomicrons, VLDL, and intermediate- density lipoprotein, IDL) by inducing the Lpl gene transcription, and indirectly by controlling the enzyme activity. This is particularly related to the ability of insulin in increasing and reducing the expression of, respectively, Apoc2 and Apoc3 genes in the liver. Conceivably, apoCII favors while apoCIII inhibits the LPL activity.
Although presenting normal food intake as compared to other experimental groups, the LS diet groups showed increased body mass, a clinical condition that is in many cases accompanied by insulin signaling impairment, hypertriglyceridemia, and liver fat accumulation. In fact, the body mass was one of the main variables associated with hepatic TG. The rise in body mass has been reported by others [20,21] and attributed to changes in energy expenditure [20] rather than increased food consumption, and to the adipogenic effects of angiotensin II [22].
Insulin resistance has previously been reported in animal models and a higher HOMA index was described in humans both submitted to intense dietary sodium restriction [5,18,23]. The insulin-resistant state that is observed in LS diets is thought to be related to the activation of RAAS and the sympathetic nervous system [23]. Moreover, the increased FFA flux to the peripheral insulin-sensitive organs such as adipose tissue and skeletal muscle impairs insulin signaling. In LDLr-KO mice, the peripheral IR elicited by the LS diet was attributed to alterations in the gastrocnemius lipidomics [4]. In the liver, the mechanisms that induce IR are less clear and may include inflammation and lipid accumulation that accompany obesity [24]. In the present investigation, it was demonstrated that dietary sodium restriction altered the expression of insulin-regulated genes that control lipid and carbohydrate metabolism in the liver. Those changes still seem incipient and could be more evident in long-term dietary salt restriction.
Particularly, an increased expression of Pck1 and G6pc was observed, contributing to the enhanced flux along the gluconeogenic pathway that characterizes hepatic IR states and enhances plasma glucose levels. It has been shown that angiotensin II increases hepatic gluconeogenesis by stimulating glycogen phosphorylase activity [25], which may have favored a hepatic insulin resistance state in the LS-S mice. In addition, the increased mRNA levels of Apoc3, which is usually downregulated by insulin, reasserts some degree of IR in the liver contributing to hypertriglyceridemia by the diminished TG hydrolysis by the LPL. On the contrary, the expression of Mttp was surprisingly reduced and may have accounted for the accumulation of TG in the liver of LS diet animals. Moreover, hepatic lipid accumulation may have been favored by the reduction in the expression of genes that control oxidative metabolism, such as Prkaa1 and 2 and Ppara, and lipolysis (Lipe), and a trend for the increased expression of Lrp1 (p = 0.059) that mediates the hepatic uptake of TG-rich lipoproteins.
A reduced expression and/or activity of AMPK in kidneys and skeletal muscle of animals submitted to an LS diet or treated with angiotensin II was previously demonstrated [26,27]. Moreover, pharmacological or genetic manipulation of AMPK and PPAR alpha are inversely associated with hepatic TG concentration, since they improve FFA metabolism by beta-oxidation [28].
The role of hepatic hormone-sensitive lipase (Lipe) in TG lipolysis is not well known. Subjects with hepatic steatosis showed an 80% reduction in hepatic hormone sensitive lipase expression expression [29], and liver-specific Lipe overexpression in mice dramatically reduced the concentration of hepatic TG [30]. However, Xia et al. (2017) did not observe changes in hepatic lipid content in mice with deletion of hepatic Lipe, suggesting that other lipases may compensate for the hormone sensitive lipase reduction [31]. In the present investigation, the expression Srebf1 was not changed while Srebf2 was reduced by the LS diet, although the involvement of this gene is preferentially related to cholesterol synthesis and LDL uptake by the B-E receptor. Hepatic glycogen, another marker of IR, was unaffected by the LS diet and those discrepancies may be related to the length of the experimental protocol and to the degree of hepatic IR that was not determined.
In addition, inflammation and glycoxidative stress elicited by LS diet [3] are related to the development of nonalcoholic steatosis [32]. Interestingly, Ddost expression was increased by the LS diet, probably as a compensatory mechanism. Many other genes related to lipid metabolism and insulin signaling were unaltered by diet or AET, which may relate to the degree of IR achieved and by the length of the experimental protocol.
Xavier et al. (2003) investigated the lipogenic effects of the LS diet and found an increased amount of lipids in rat carcasses and retroperitoneal fat pads, but not in the liver despite an increase in hepatic lipogenesis, which may be ascribed to the different animal model utilized by them. Insulin resistance triggers liver steatosis by disturbing the balance among lipid synthesis, clearance, and lipoprotein uptake [6].
Changes in lifestyle represent the first line for the treatment of hepatic steatosis [33], and several studies have demonstrated a protective role of exercise training in preventing liver fat accumulation, regardless of body weight loss and even in a low-volume and low-intensity program [34,35,36,37]. The increase in fatty acid oxidation, mitochondrial biogenesis and damage prevention, and reduction of lipogenesis and insulin resistance in the liver and peripheral organs are the major effects of exercise. Accordingly, it was observed in the present investigation that AET reduced insulin resistance optimizing glucose disposal rate in the kITT. Moreover, exercise training reduced intrahepatic TG accumulation, which was associated with increased citrate synthase activity that positively correlated with AET capacity (time to exhaustion test). Nonetheless, the effects of exercise training on gene expression were not evidenced, which may be related to the exercise intensity. The exercise intensity was not adjusted throughout the experimental protocol, and the velocity of running (15 m/min) represented between 56% (at first week) and 39% (at the final) of peak speed in the progressive exercise test, suggesting moderate- to low-intensity physical training.
The present investigation has some limitations. There are no ideal mouse models that fully mimic the particularities of human glycolipid metabolism as well as the pathophysiology of human dyslipidemia, insulin resistance, and metabolic syndrome. Several animal models have been established to investigate the mechanisms of dyslipidemia and insulin resistance, which are some of the main risk factors for cardiovascular disease morbidity and mortality. The selection of an experimental model that enables a satisfactory understanding of the systemic and hepatic effects of dietary sodium restriction is extremely complex, since all animal models show advantages and disadvantages. Considering all of the experimental limitations, the LDLr-KO mice allow the investigation of the dietary sodium restriction effects on hepatic tissue and, simultaneously, reduce the influence of some important interfering factors on the experimental design. They include in wild-type mice the use of a high-fat diet containing cholic acid or a diet high in fats and sucrose that may induce hepatotoxicity and inflammation. Although the obtained results must be confirmed in humans, the use of LDLr-KO mice—a model that mimics the pathophysiology of human dyslipidemia—in the current study, allowed showing important adverse effects of dietary sodium restriction on the liver and their modulation by aerobic exercise training, accentuating the clinical perspective of the present investigation.
People with dyslipidemia and metabolic syndrome are at high risk of non-alcoholic fatty liver disease, hypertension, and cardiovascular disease, which make them important candidates for dietary sodium restriction. Results in dyslipidemic LDLr-KO mice agree with other studies in Wistar rats [6] and wild-type mice [7] that showed increased hepatic lipogenesis and dyslipidemia induced by the LS diet. However, observational data in humans associate sodium restriction with a lower odds ratio for non-alcoholic fatty liver disease [38,39,40]. Considering that dietary sodium intake is also related to other nutritional components and alimentary habits, clinical trials are necessary to translate results from murine models to human health.
Although the salt restriction was quite intense in the experimental protocol utilized, to the best of our knowledge this is the first demonstration that the LS diet alone induces TG accumulation in the liver due to IR and altered gene expression. Liver TG was positively related to body mass and plasma TG levels and inversely correlated with sodium urinary excretion, and glucose decay rate. It is noteworthy that although data obtained in this investigation refer to gene expressions that in some cases do not reflect protein content and/or activity, findings are in line with the biochemical assessment of TG content in the liver and with the assessment of IR by the kITT.
Importantly, the results evidence that AET is an important tool to mitigate the deleterious effects of the LS diet in lipid and glucose homeostasis avoiding systemic IR and liver steatosis. Exercise performance negatively correlated with the amount of TG in the liver. This is particularly important, considering that the benefits of dietary sodium restriction in reducing BP can be maintained in association with regular exercise and deserves further investigation in humans.

5. Conclusions

Intensive dietary sodium restriction in LDL receptor knockout mice increased body mass, triglyceridemia, glycemia, and IR. In the liver, the LS diet favored TG accumulation, which was associated with modulation in the expression of genes related to gluconeogenesis, VLDL uptake and assembly, lipolysis, and oxidative metabolism. Aerobic exercise training prevented lipid accumulation in the liver due to its protective role in stimulating hepatic oxidative metabolism and reducing peripheral insulin resistance.

Author Contributions

Conceptualization, M.P., S.C., and U.F.M.; methodology, G.d.S.F., P.R.P., V.D.B., A.P.G.B., L.G.R., M.R.P.T.M., S.C., and M.P.; formal analysis, G.d.S.F.; investigation, G.d.S.F., P.R.P., V.D.B., A.P.G.B., and E.R.N.; data curation, G.d.S.F.; writing—original draft preparation, G.d.S.F.; writing—review and editing, M.P. and S.C.; validation, G.d.S.F.; visualization, G.d.S.F.; supervision, M.P. and S.C.; resources, M.P., S.C., and U.F.M.; project administration, M.P. and S.C.; funding acquisition, M.P. and U.F.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by a Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP grant to MP and UFM (#2016/15603-0), and a Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001 grant to GSF. MP and UFM are recipients of a research award from the Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, Brazil.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethics Committee of the Faculdade de Medicina da Universidade de São Paulo (# 1210/2019; 18 April 2019).

Data Availability Statement

All data reported are included in the manuscript and upon personal request to the authors raw data can be kindly shared. This article includes original data and only kITT and biochemical data of the LS and NS groups were shared with another previous publication as informed.

Acknowledgments

The authors would like to thank Mayara S. Trevisani for helping with the initial experiments with mice, Antonio dos Santos Filho for helping with animal care, Luzia N. S. Furukawa for assistance in urinary sodium excretion analysis, and Aritania S. Santos and Chin J. Lin for providing facilities for gene expression experiments.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. WHO. Guideline: Sodium Intake for Adults and Children; World Health Organization: Geneva, Switzerland, 2012. [Google Scholar]
  2. O’Donnell, M.; Mente, A.; Rangarajan, S.; McQueen, M.J.; O’Leary, N.; Yin, L.; Liu, X.; Swaminathan, S.; Khatib, R.; Rosengren, A.; et al. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: Prospective cohort study. BMJ 2019, 364. [Google Scholar] [CrossRef] [Green Version]
  3. Fusco, F.B.; Gomes, D.J.; Bispo, K.C.S.; Toledo, V.P.; Barbeiro, D.F.; Capelozzi, V.L.; Furukawa, L.N.S.; Velosa, A.P.P.; Teodoro, W.R.; Heimann, J.C.; et al. Low-sodium diet induces atherogenesis regardless of lowering blood pressure in hypertensive hyperlipidemic mice. PLoS ONE 2017, 12. [Google Scholar] [CrossRef]
  4. Pinto, P.R.; Yoshinaga, M.Y.; Del Bianco, V.; Bochi, A.P.; Ferreira, G.S.; Pinto, I.F.D.; Rodrigues, L.G.; Nakandakare, E.R.; Okamoto, M.M.; Machado, U.F.; et al. Dietary sodium restriction alters muscle lipidomics that relates to insulin resistance in mice. J. Biol. Chem. 2021, 296, 100344. [Google Scholar] [CrossRef] [PubMed]
  5. Prada, P.O.; Coelho, M.S.; Gottardello Zecchin, H.; Dolnikoff, M.S.; Gasparetti, A.L.; Shinohara Furukawa, L.N.; Abdalla Saad, M.J.; Heimann, J.C. Low salt intake modulates insulin signaling, JNK activity and IRS-1ser307 phosphorylation in rat tissues. J. Endocrinol. 2005, 185, 429–437. [Google Scholar] [CrossRef]
  6. Xavier, A.R.; Garófalo, M.A.R.; Migliorini, R.H.; Kettelhut, I.C. Dietary sodium restriction exacerbates age-related changes in rat adipose tissue and liver lipogenesis. Metabolism 2003, 52, 1072–1077. [Google Scholar] [CrossRef]
  7. Cabrera, D.; Rao, I.; Raasch, F.; Solis, N.; Pizarro, M.; Freire, M.; Sáenz De Urturi, D.; Ramírez, C.A.; Triantafilo, N.; León, J.; et al. Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice. Ann. Hepatol. 2021, 24, 100357. [Google Scholar] [CrossRef]
  8. Rocco, D.D.F.M.; Okuda, L.S.; Pinto, R.S.; Ferreira, F.D.; Kubo, S.K.; Nakandakare, E.R.; Quintão, E.C.R.; Catanozi, S.; Passarelli, M. Aerobic exercise improves reverse cholesterol transport in cholesteryl ester transfer protein transgenic mice. Lipids 2011, 46, 617–625. [Google Scholar] [CrossRef]
  9. Sarzynski, M.A.; Burton, J.; Rankinen, T.; Blair, S.N.; Church, T.S.; Després, J.-P.; Hagberg, J.M.; Landers-Ramos, R.; Leon, A.S.; Mikus, C.R.; et al. The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions. Atherosclerosis 2015, 243, 364–372. [Google Scholar] [CrossRef] [Green Version]
  10. Romero-Gómez, M.; Zelber-Sagi, S.; Trenell, M. Treatment of NAFLD with diet, physical activity and exercise. J. Hepatol. 2017, 67, 829–846. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Stevanović, J.; Beleza, J.; Coxito, P.; Ascensão, A.; Magalhães, J. Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease. Mol. Metab. 2020, 32, 1–14. [Google Scholar] [CrossRef]
  12. Ferreira, J.C.B.; Rolim, N.P.L.; Bartholomeu, J.B.; Gobatto, C.A.; Kokubun, E.; Brum, P.C. Maximal lactate steady state in running mice: Effect of exercise training. Clin. Exp. Pharmacol. Physiol. 2007, 34, 760–765. [Google Scholar] [CrossRef] [PubMed]
  13. Carr, T.P.; Andresen, C.J.; Rudel, L.L. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 1993, 26, 39–42. [Google Scholar] [CrossRef]
  14. Lowry, O.H.; Rosenbrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the folin. J. Biol. Chem. 1951, 193, 265–275. [Google Scholar] [CrossRef]
  15. Livak, K.J.; Schmittgen, T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
  16. Catanozi, S.; Rocha, J.C.; Passarelli, M.; Guzzo, M.L.; Alves, C.; Furukawa, L.N.S.; Nunes, V.S.; Nakandakare, E.R.; Heimann, J.C.; Quintão, E.C.R. Dietary sodium chloride restriction enhances aortic wall lipid storage and raises plasma lipid concentration in LDL receptor knockout mice. J. Lipid Res. 2003, 44, 727–732. [Google Scholar] [CrossRef] [Green Version]
  17. Graudal, N.A.; Hubeck-Graudal, T.; Jurgens, G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst. Rev. 2020, 12, CD004022. [Google Scholar] [CrossRef]
  18. Nakandakare, E.R.; Charf, A.M.; Santos, F.C.; Nunes, V.S.; Ortega, K.; Lottenberg, A.M.P.; Mion, D.; Nakano, T.; Nakajima, K.; D’Amico, E.A.; et al. Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients. Atherosclerosis 2008, 200, 410–416. [Google Scholar] [CrossRef] [PubMed]
  19. Catanozi, S.; Rocha, J.C.; Nakandakare, E.R.; Passarelli, M.; Mesquita, C.H.; Silva, A.A.; Dolnikoff, M.S.; Harada, L.M.; Quintão, E.C.R.; Heimann, J.C. The rise of the plasma lipid concentration elicited by dietary sodium chloride restriction in Wistar rats is due to an impairment of the plasma triacylglycerol removal rate. Atherosclerosis 2001, 158, 81–86. [Google Scholar] [CrossRef]
  20. Coelho, M.S.; Passadore, M.D.; Gasparetti, A.L.; Bibancos, T.; Prada, P.O.; Furukawa, L.L.; Furukawa, L.N.S.; Fukui, R.T.; Casarini, D.E.; Saad, M.J.A.; et al. High- or low-salt diet from weaning to adulthood: Effect on body weight, food intake and energy balance in rats. Nutr. Metab. Cardiovasc. Dis. 2006, 16, 148–155. [Google Scholar] [CrossRef]
  21. De Prada, P.O.; Okamoto, M.M.; Furukawa, L.N.S.; Machado, U.F.; Heimann, J.C.; Dolnikoff, M.S. High- or low-salt diet from weaning to adulthood: Effect on insulin sensitivity in Wistar rats. Hypertension 2000, 35, 424–429. [Google Scholar] [CrossRef] [Green Version]
  22. Yvan-Charvet, L.; Quignard-Boulangé, A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int. 2011, 79, 162–168. [Google Scholar] [CrossRef] [PubMed]
  23. Oh, H.; Lee, H.Y.; Jun, D.W.; Lee, S.M. Low Salt Diet and Insulin Resistance. Clin. Nutr. Res. 2016, 5, 1–6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Jung, U.J.; Choi, M.-S. Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2014, 15, 6184–6223. [Google Scholar] [CrossRef] [Green Version]
  25. Keppens, S.; Vandekerckhove, A.; Moshage, H.; Yap, S.H.; Aerts, R.; de Wulf, H. Regulation of glycogen phosphorylase activity in isolated human hepatocytes. Hepatology 1993, 17, 610–614. [Google Scholar] [CrossRef]
  26. Liu, J.; Li, X.; Lu, Q.; Ren, D.; Sun, X.; Rousselle, T.; Li, J.; Leng, J. AMPK: A balancer of the renin–angiotensin system. Biosci. Rep. 2019, 39, BSR20181994. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Udwan, K.; Abed, A.; Roth, I.; Dizin, E.; Maillard, M.; Bettoni, C.; Loffing, J.; Wagner, C.A.; Edwards, A.; Feraille, E. Dietary sodium induces a redistribution of the tubular metabolic workload. J. Physiol. 2017, 595, 6905–6922. [Google Scholar] [CrossRef] [Green Version]
  28. Boudaba, N.; Marion, A.; Huet, C.; Pierre, R.; Viollet, B.; Foretz, M. AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development. EBioMedicine 2018, 28, 194–209. [Google Scholar] [CrossRef] [Green Version]
  29. Kohjima, M.; Enjoji, M.; Higuchi, N.; Kato, M.; Kotoh, K.; Yoshimoto, T.; Fujino, T.; Yada, M.; Yada, R.; Harada, N.; et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 2007, 20, 351–358. [Google Scholar] [CrossRef] [Green Version]
  30. Reid, B.N.; Ables, G.P.; Otlivanchik, O.A.; Schoiswohl, G.; Zechner, R.; Blaner, W.S.; Goldberg, I.J.; Schwabe, R.F.; Chua, S.C.; Huang, L.S. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J. Biol. Chem. 2008, 283, 13087–13099. [Google Scholar] [CrossRef] [Green Version]
  31. Xia, B.; Cai, G.H.; Yang, H.; Wang, S.P.; Mitchell, G.A.; Wu, J.W. Adipose tissue deficiency of hormone-sensitive lipase causes fatty liver in mice. PLoS Genet. 2017, 13. [Google Scholar] [CrossRef] [Green Version]
  32. Palma-Duran, S.A.; Kontogianni, M.D.; Vlassopoulos, A.; Zhao, S.; Margariti, A.; Georgoulis, M.; Papatheodoridis, G.; Combet, E. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults. Metabolism 2018, 83, 120–127. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Vilar-Gomez, E.; Martinez-Perez, Y.; Calzadilla-Bertot, L.; Torres-Gonzalez, A.; Gra-Oramas, B.; Gonzalez-Fabian, L.; Friedman, S.L.; Diago, M.; Romero-Gomez, M. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 2015, 149, 367–378.e5. [Google Scholar] [CrossRef]
  34. Johnson, N.A.; Sachinwalla, T.; Walton, D.W.; Smith, K.; Armstrong, A.; Thompson, M.W.; George, J. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009, 50, 1105–1112. [Google Scholar] [CrossRef] [PubMed]
  35. Hashida, R.; Kawaguchi, T.; Bekki, M.; Omoto, M.; Matsuse, H.; Nago, T.; Takano, Y.; Ueno, T.; Koga, H.; George, J.; et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J. Hepatol. 2017, 66, 142–152. [Google Scholar] [CrossRef] [PubMed]
  36. Keating, S.E.; Hackett, D.A.; Parker, H.M.; O’Connor, H.T.; Gerofi, J.A.; Sainsbury, A.; Baker, M.K.; Chuter, V.H.; Caterson, I.D.; George, J.; et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J. Hepatol. 2015, 63, 174–182. [Google Scholar] [CrossRef] [PubMed]
  37. Bagheri, M.; Azamian-Jazi, A.; Banitalebi, E.; Kazeminasab, F.; Hossein Nasr-Esfahani, M. Both high-intensity interval training and low-intensity endurance training decrease intrahepatic lipid deposits via alterations of the expression of HIF-1α, HIG2 in a murine model of NAFLD. Sci. Sports 2020. [Google Scholar] [CrossRef]
  38. van den Berg, E.H.; Gruppen, E.G.; Blokzijl, H.; Bakker, S.J.L.; Dullaart, R.P.F. Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study. J. Clin. Med. 2019, 8, 2157. [Google Scholar] [CrossRef] [Green Version]
  39. Choi, Y.; Lee, J.E.; Chang, Y.; Kim, M.K.; Sung, E.; Shin, H.; Ryu, S. Dietary sodium and potassium intake in relation to non-alcoholic fatty liver disease. Br. J. Nutr. 2016, 116, 1447–1456. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Emamat, H.; Farhadnejad, H.; Movahedian, M.; Tangestani, H.; Mirmiran, P.; Hekmatdoost, A. Dietary sodium intake in relation to non-alcoholic fatty liver disease risk: A case-control study. Nutr. Food Sci. 2021, 51, 541–550. [Google Scholar] [CrossRef]
Nutrients 13 02174 g001 550
Figure 1. Urinary sodium excretion (mEq/24 h). Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise). p value shows difference between NS and LS groups. p exercise = 0.94; p diet*exercise = 0.94. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Figure 1. Urinary sodium excretion (mEq/24 h). Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise). p value shows difference between NS and LS groups. p exercise = 0.94; p diet*exercise = 0.94. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Nutrients 13 02174 g001
Nutrients 13 02174 g002 550
Figure 2. Time to exhaustion in treadmill exercise test before and after AET. Data presented as mean ± SD. Results compared by 3-way ANOVA (random factor: animal; fixed factor: time, diet and exercise) with Tukey’s post hoc test. p exercise*time < 0.01; p exercise*diet*time = 0.32. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained. NS-S n = 14; NS-T n = 13; LS-S n = 13; LS-T n = 13.
Figure 2. Time to exhaustion in treadmill exercise test before and after AET. Data presented as mean ± SD. Results compared by 3-way ANOVA (random factor: animal; fixed factor: time, diet and exercise) with Tukey’s post hoc test. p exercise*time < 0.01; p exercise*diet*time = 0.32. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained. NS-S n = 14; NS-T n = 13; LS-S n = 13; LS-T n = 13.
Nutrients 13 02174 g002
Nutrients 13 02174 g003 550
Figure 3. Glucose decay rate in insulin tolerance test (kITT, % min). Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. p diet = 0.02; p exercise = 0.02; p diet*exercise = 0.02. Distinct letters represent statistical differences among groups (p < 0.05). NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Figure 3. Glucose decay rate in insulin tolerance test (kITT, % min). Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. p diet = 0.02; p exercise = 0.02; p diet*exercise = 0.02. Distinct letters represent statistical differences among groups (p < 0.05). NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Nutrients 13 02174 g003
Nutrients 13 02174 g004a 550Nutrients 13 02174 g004b 550
Figure 4. Percentual of plasma lipids in lipoproteins determined by FPLC. (a) VLDLc; (b) LDLc; (c) HDLc; (d) VLDLtg; (e) LDLtg; (f) HDLtg. Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. p values show differences between diets. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Figure 4. Percentual of plasma lipids in lipoproteins determined by FPLC. (a) VLDLc; (b) LDLc; (c) HDLc; (d) VLDLtg; (e) LDLtg; (f) HDLtg. Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. p values show differences between diets. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Nutrients 13 02174 g004aNutrients 13 02174 g004b
Nutrients 13 02174 g005 550
Figure 5. Concentration of hepatic lipids and glycogen, and liver mass. (a) Triglycerides (mg/g of tissue); (b) cholesterol (mg/of tissue); (c) triglycerides (mg/g of protein); (d) cholesterol (mg/g of protein); (e) glycogen (% of stained area); (f) liver mass (g/100 g of body mass). Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. Distinct letters represent statistical differences between groups (p < 0.05). NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Figure 5. Concentration of hepatic lipids and glycogen, and liver mass. (a) Triglycerides (mg/g of tissue); (b) cholesterol (mg/of tissue); (c) triglycerides (mg/g of protein); (d) cholesterol (mg/g of protein); (e) glycogen (% of stained area); (f) liver mass (g/100 g of body mass). Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. Distinct letters represent statistical differences between groups (p < 0.05). NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Nutrients 13 02174 g005
Nutrients 13 02174 g006 550
Figure 6. Correlation between liver triglycerides (mg/g of protein) and body mass, biochemical variables, and exercise treadmill test. (a) Liver triglycerides (mg/g of protein) and body mass (g); (b) liver triglycerides (mg/g of protein) and plasma triglycerides (mg/dL); (c) liver triglycerides (mg/g of protein) and urinary sodium excretion (mEq/24 h); (d) liver triglycerides (mg/g of protein) and glucose decay rate, kITT (% min); (e) liver triglycerides (mg/g of protein) and time to exhaustion in treadmill exercise test (s). Correlations were performed by the Spearman’s rank correlation test.
Figure 6. Correlation between liver triglycerides (mg/g of protein) and body mass, biochemical variables, and exercise treadmill test. (a) Liver triglycerides (mg/g of protein) and body mass (g); (b) liver triglycerides (mg/g of protein) and plasma triglycerides (mg/dL); (c) liver triglycerides (mg/g of protein) and urinary sodium excretion (mEq/24 h); (d) liver triglycerides (mg/g of protein) and glucose decay rate, kITT (% min); (e) liver triglycerides (mg/g of protein) and time to exhaustion in treadmill exercise test (s). Correlations were performed by the Spearman’s rank correlation test.
Nutrients 13 02174 g006
Nutrients 13 02174 g007 550
Figure 7. Relative gene expression (2−ΔΔCT) of proteins related to lipid and carbohydrate metabolism and inflammation. Gene expression evaluated in liver homogenates. (a) Genes with statistical significance between intervention. (b) Genes without statistical difference. Data presented as mean ± range. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. Distinct letters represent statistical differences among groups (p < 0.05). “Diet” = p < 0.05 NS vs. LS. Exercise = p < 0.05 S vs. T. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained. Apoc3, apolipoprotein c-III; Lipe, lipase, hormone sensitive; Lrp1, low density lipoprotein receptor-related protein 1; Mttp, microsomal triglyceride transfer protein; Ppara, peroxisome proliferator activated receptor alpha; Prkaa1 and 2, protein kinase, AMP-activated, alpha 1 and alpha 2 catalytic subunit; Srebf1 and 2, sterol regulatory element binding transcription factor 1 and 2; G6pc, glucose-6-phosphatase, catalytic; Pck1, phosphoenolpyruvate carboxykinase 1, cytosolic; Ddost, dolichyl-di-phosphooligosaccharide-protein glycotransferase; Acaca, acetyl-Coenzyme A carboxylase alpha; Apoc2, Apolipoprotein c-II; Fasn, fatty acid synthase; Plin1, perilipin 1; Ppargc1a, peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; Foxa2, forkhead box A2; Foxo1, forkhead box O1; Slc2a2, solute carrier family 2 (facilitated glucose transporter), member 2; Ager, advanced glycosylation end product-specific receptor; Il6, Interleukin-6; Il10, Interleukin-10; Rela, v-rel reticuloendotheliosis viral oncogene homolog A.
Figure 7. Relative gene expression (2−ΔΔCT) of proteins related to lipid and carbohydrate metabolism and inflammation. Gene expression evaluated in liver homogenates. (a) Genes with statistical significance between intervention. (b) Genes without statistical difference. Data presented as mean ± range. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. Distinct letters represent statistical differences among groups (p < 0.05). “Diet” = p < 0.05 NS vs. LS. Exercise = p < 0.05 S vs. T. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained. Apoc3, apolipoprotein c-III; Lipe, lipase, hormone sensitive; Lrp1, low density lipoprotein receptor-related protein 1; Mttp, microsomal triglyceride transfer protein; Ppara, peroxisome proliferator activated receptor alpha; Prkaa1 and 2, protein kinase, AMP-activated, alpha 1 and alpha 2 catalytic subunit; Srebf1 and 2, sterol regulatory element binding transcription factor 1 and 2; G6pc, glucose-6-phosphatase, catalytic; Pck1, phosphoenolpyruvate carboxykinase 1, cytosolic; Ddost, dolichyl-di-phosphooligosaccharide-protein glycotransferase; Acaca, acetyl-Coenzyme A carboxylase alpha; Apoc2, Apolipoprotein c-II; Fasn, fatty acid synthase; Plin1, perilipin 1; Ppargc1a, peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; Foxa2, forkhead box A2; Foxo1, forkhead box O1; Slc2a2, solute carrier family 2 (facilitated glucose transporter), member 2; Ager, advanced glycosylation end product-specific receptor; Il6, Interleukin-6; Il10, Interleukin-10; Rela, v-rel reticuloendotheliosis viral oncogene homolog A.
Nutrients 13 02174 g007
Nutrients 13 02174 g008 550
Figure 8. Citrate synthase activity (nmol/min/mg of protein) and correlation between citrate synthase activity (nmol/min/mg of protein) and time to exhaustion in treadmill exercise test. Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. Correlation was performed by Spearman’s rank correlation test (b). In (a), p diet < 0.01; p exercise < 0.01; p diet*exercise = 0.04. Distinct letters represent statistical differences among groups (p < 0.05). NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Figure 8. Citrate synthase activity (nmol/min/mg of protein) and correlation between citrate synthase activity (nmol/min/mg of protein) and time to exhaustion in treadmill exercise test. Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise) with Tukey’s post hoc test. Correlation was performed by Spearman’s rank correlation test (b). In (a), p diet < 0.01; p exercise < 0.01; p diet*exercise = 0.04. Distinct letters represent statistical differences among groups (p < 0.05). NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained.
Nutrients 13 02174 g008
Table
Table 1. Characterization of groups before intervention.
Table 1. Characterization of groups before intervention.
NS-S (n = 12–14)NS-T (n = 13–11)LS-S (n = 13–11)LS-T (n = 13–10)p
Body Mass (g)24 ± 225 ± 125 ± 224 ± 20.76
TC (mg/dL)268 ± 36255 ± 37288 ± 34265 ± 400.15
TG (mg/dL)168 ± 36150 ± 24157 ± 32152 ± 260.37
Glucose (mg/dL)93 ± 1293 ± 893 ± 1495 ± 140.93
Hematocrit (%)49 ± 549 ± 749 ± 751 ± 50.87
SBP (mmHg)109 ± 8113 ± 6111 ± 6111 ± 50.44
DBP (mmHg)47 ± 844 ± 746 ± 1448 ± 90.85
HR (bpm)522 ± 75481 ± 55484 ± 53475 ± 820.39
Data presented as mean ± SD. Results compared by one-way ANOVA. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained; TC = total cholesterol; TG = triglycerides; SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate.
Table
Table 2. Characterization of groups after intervention.
Table 2. Characterization of groups after intervention.
NS-S (n = 14–12)NS-T (n = 13–11)LS-S (n = 13–11)LS-T (n = 13–11)p
Body Mass (g)26 ± 326 ± 229 ± 527 ± 2Diet
TC * (mg/dL)271 ± 103304 ± 91254 ± 96292 ± 83-
TG * (mg/dL)101 ± 9100 ± 27152 ± 36130 ± 51Diet
Glucose (mg/dL)100 ± 15115 ± 20115 ± 20124 ± 22Diet Exercise
Hematocrit (%)48 ± 350 ± 350 ± 351 ± 5-
SBP (mmHg)106 ± 6106 ± 6105 ± 8102 ± 5-
DBP (mmHg)46 ± 849 ± 1444 ± 946 ± 11-
HR (bpm)531 ± 60531 ± 46535 ± 61530 ± 63-
Data presented as mean ± SD. Results compared by 2-way ANOVA (GLM; fixed factor: diet and exercise). “Diet” = p < 0.05 for NS vs. LS; “Exercise” = p < 0.05 for S vs. T. NS = normal-sodium diet; LS = low-sodium diet; S = sedentary; T = trained; TC = total cholesterol; TG = triglycerides; SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate. * (n = 3–5).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

da Silva Ferreira, G.; Bochi, A.P.G.; Pinto, P.R.; Del Bianco, V.; Rodrigues, L.G.; Morais, M.R.P.T.; Nakandakare, E.R.; Machado, U.F.; Catanozi, S.; Passarelli, M. Aerobic Exercise Training Prevents Insulin Resistance and Hepatic Lipid Accumulation in LDL Receptor Knockout Mice Chronically Fed a Low-Sodium Diet. Nutrients 2021, 13, 2174. https://doi.org/10.3390/nu13072174

AMA Style

da Silva Ferreira G, Bochi APG, Pinto PR, Del Bianco V, Rodrigues LG, Morais MRPT, Nakandakare ER, Machado UF, Catanozi S, Passarelli M. Aerobic Exercise Training Prevents Insulin Resistance and Hepatic Lipid Accumulation in LDL Receptor Knockout Mice Chronically Fed a Low-Sodium Diet. Nutrients. 2021; 13(7):2174. https://doi.org/10.3390/nu13072174

Chicago/Turabian Style

da Silva Ferreira, Guilherme, Ana Paula Garcia Bochi, Paula Ramos Pinto, Vanessa Del Bianco, Letícia Gomes Rodrigues, Mychel Raony Paiva Teixeira Morais, Edna Regina Nakandakare, Ubiratan Fabres Machado, Sergio Catanozi, and Marisa Passarelli. 2021. "Aerobic Exercise Training Prevents Insulin Resistance and Hepatic Lipid Accumulation in LDL Receptor Knockout Mice Chronically Fed a Low-Sodium Diet" Nutrients 13, no. 7: 2174. https://doi.org/10.3390/nu13072174

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop